Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 613

Similar articles for PubMed (Select 18410283)

1.

Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.

Appenrodt B, Wolf A, Grünhage F, Trebicka J, Schepke M, Rabe C, Lammert F, Sauerbruch T, Heller J.

Liver Int. 2008 Aug;28(7):1019-25. doi: 10.1111/j.1478-3231.2008.01734.x. Epub 2008 Apr 11.

PMID:
18410283
2.

Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.

Hamdy H, ElBaz AA, Hassan A, Hassanin O.

J Clin Gastroenterol. 2014 Feb;48(2):184-8. doi: 10.1097/MCG.0b013e31829ae376.

PMID:
23842215
3.

Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.

Singh V, Dheerendra PC, Singh B, Nain CK, Chawla D, Sharma N, Bhalla A, Mahi SK.

Am J Gastroenterol. 2008 Jun;103(6):1399-405. doi: 10.1111/j.1572-0241.2008.01787.x.

PMID:
18547224
4.

Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.

Moreau R, Asselah T, Condat B, de Kerguenec C, Pessione F, Bernard B, Poynard T, Binn M, Grangé JD, Valla D, Lebrec D.

Gut. 2002 Jan;50(1):90-4.

5.

Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.

Singh V, Kumar R, Nain CK, Singh B, Sharma AK.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):303-7.

PMID:
16460491
6.

Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.

Singh V, Kumar B, Nain CK, Singh B, Sharma N, Bhalla A, Sharma AK.

J Intern Med. 2006 Jul;260(1):62-8.

PMID:
16789980
7.

Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.

Fernández-Esparrach G, Guevara M, Sort P, Pardo A, Jiménez W, Ginès P, Planas R, Lebrec D, Geuvel A, Elewaut A, Adler M, Arroyo V.

J Hepatol. 1997 Mar;26(3):614-20. Erratum in: J Hepatol 1997 Jun;26(6):1430.

PMID:
9075669
8.

Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.

Sola-Vera J, Miñana J, Ricart E, Planella M, González B, Torras X, Rodríguez J, Such J, Pascual S, Soriano G, Pérez-Mateo M, Guarner C.

Hepatology. 2003 May;37(5):1147-53.

PMID:
12717396
9.

Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.

Planas R, Ginès P, Arroyo V, Llach J, Panés J, Vargas V, Salmerón JM, Ginès A, Toledo C, Rimola A, et al.

Gastroenterology. 1990 Dec;99(6):1736-44.

PMID:
1699835
10.

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, Morgando A, Marzano A, Rizzetto M.

Dig Liver Dis. 2011 Nov;43(11):881-6. doi: 10.1016/j.dld.2011.06.001. Epub 2011 Jul 8.

PMID:
21741331
11.

The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites--a randomized multicentric study.

Lata J, Marecek Z, Fejfar T, Zdenek P, Brůha R, Safka V, Hůlek P, Hejda V, Dolina J, Stehlík J, Tozzi I.

Hepatogastroenterology. 2007 Oct-Nov;54(79):1930-3.

PMID:
18251131
12.

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.

Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Solà R, Ginès P, Terg R, Inglada L, Vaqué P, Salerno F, Vargas V, Clemente G, Quer JC, Jiménez W, Arroyo V, Rodés J.

Gastroenterology. 1996 Oct;111(4):1002-10.

PMID:
8831595
13.

Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.

Vila MC, Solà R, Molina L, Andreu M, Coll S, Gana J, Marquez J, Palá J, Bory F, Pons S, Szescielinski L, Jimenez W.

J Hepatol. 1998 Apr;28(4):639-45.

PMID:
9566833
14.

Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.

Sersté T, Francoz C, Durand F, Rautou PE, Melot C, Valla D, Moreau R, Lebrec D.

J Hepatol. 2011 Oct;55(4):794-9. doi: 10.1016/j.jhep.2011.01.034. Epub 2011 Feb 24.

PMID:
21354230
15.
16.

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, Torres M, Humbert P, Rimola A, Llach J, et al.

Gastroenterology. 1988 Jun;94(6):1493-502.

PMID:
3360270
17.

The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.

Tandon P, Tsuyuki RT, Mitchell L, Hoskinson M, Ma MM, Wong WW, Mason AL, Gutfreund K, Bain VG.

Liver Int. 2009 Feb;29(2):169-74. doi: 10.1111/j.1478-3231.2008.01778.x. Epub 2008 May 19.

PMID:
18492024
18.

Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.

Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM.

Am J Gastroenterol. 1997 Mar;92(3):394-9.

PMID:
9068457
19.

The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.

Bari K, Miñano C, Shea M, Inayat IB, Hashem HJ, Gilles H, Heuman D, Garcia-Tsao G.

Clin Gastroenterol Hepatol. 2012 Oct;10(10):1169-75. doi: 10.1016/j.cgh.2012.06.027. Epub 2012 Jul 16.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk